PE20140397A1 - Derivados de fluoro-piridinona utiles como agentes antibacterianos - Google Patents

Derivados de fluoro-piridinona utiles como agentes antibacterianos

Info

Publication number
PE20140397A1
PE20140397A1 PE2013002016A PE2013002016A PE20140397A1 PE 20140397 A1 PE20140397 A1 PE 20140397A1 PE 2013002016 A PE2013002016 A PE 2013002016A PE 2013002016 A PE2013002016 A PE 2013002016A PE 20140397 A1 PE20140397 A1 PE 20140397A1
Authority
PE
Peru
Prior art keywords
fluoro
hydroxy
antibacterial agents
derivatives useful
pyridinone derivatives
Prior art date
Application number
PE2013002016A
Other languages
English (en)
Inventor
Mathew Frank Brown
Ye Che
Michael Joseph Melnick
Justin Ian Montgomery
Mark Stephen Plummer
Loren Michael Price
Usa Reilly
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PE20140397A1 publication Critical patent/PE20140397A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE REFIERE A COMPUESTOS DERIVADOS DE FLUORO-PIRIDINONA DE FORMULA (I) DONDE R1 ES ALQUILO(C1-C3); R2 ES H O ALQUILO(C1-C3); R3 ES H, HALOGENO, HIDROXI, CN, ENTRE OTROS; T ES ETINILO, ARILO(C6-C10) O HETEROARILO; D ESTA AUSENTE O ES UN ENLACE, (CH2)r O (CH2)n-O-(CH2)p, EN DONDE r ES DE 1 A 3; n Y p SON CADA UNO DE 0 A 2; E ESTA AUSENTE O ES CICLOALQUILO(C3-C10), ARILO(C6-C10), ENTRE OTROS. SON COMPUESTOS PREFERIDOS: (2R)-4-{5-FLUORO-2-OXO-4-[4-(2H-1,2,3-TRIAZOL-2-IL)FENIL]PIRIDIN-1(2H)-IL}-N-HIDROXI-2-METIL-2-(METILSULFONIL)BUTANAMIDA; (2R)-4-[5-FLUORO-4-(2-FLUORO-4-METOXIFENIL)-2-OXOPIRIDIN-1(2H)-IL]-N-HIDROXI-2-METIL-2-(METILSULFONIL)BUTANAMIDA; ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON ANTIBACTERIANOS EN ESPECIAL CONTRA GRAM-NEGATIVOS SIENDO UTILES EN EL TRATAMIENTO DE INFECCIONES BACTERIANAS
PE2013002016A 2011-03-07 2012-02-22 Derivados de fluoro-piridinona utiles como agentes antibacterianos PE20140397A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161449825P 2011-03-07 2011-03-07

Publications (1)

Publication Number Publication Date
PE20140397A1 true PE20140397A1 (es) 2014-03-28

Family

ID=45841548

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2013002016A PE20140397A1 (es) 2011-03-07 2012-02-22 Derivados de fluoro-piridinona utiles como agentes antibacterianos

Country Status (33)

Country Link
US (2) US8624034B2 (es)
EP (1) EP2683689B1 (es)
JP (1) JP5620020B2 (es)
KR (1) KR101593288B1 (es)
CN (2) CN103443079B (es)
AP (1) AP3336A (es)
AR (1) AR085615A1 (es)
AU (1) AU2012226473B8 (es)
BR (1) BR112013022536B1 (es)
CA (1) CA2828337C (es)
CL (1) CL2013002417A1 (es)
CO (1) CO6761338A2 (es)
CR (1) CR20130403A (es)
CU (1) CU20130117A7 (es)
DO (1) DOP2013000200A (es)
EA (1) EA024782B1 (es)
EC (1) ECSP13012928A (es)
ES (1) ES2626457T3 (es)
GE (1) GEP20156370B (es)
GT (1) GT201300213A (es)
HK (2) HK1191951A1 (es)
IL (1) IL228100A0 (es)
MA (1) MA34963B1 (es)
MX (1) MX341977B (es)
NI (1) NI201300077A (es)
PE (1) PE20140397A1 (es)
SG (1) SG192766A1 (es)
TN (1) TN2013000353A1 (es)
TW (1) TWI453197B (es)
UA (1) UA107423C2 (es)
UY (1) UY33936A (es)
WO (1) WO2012120397A1 (es)
ZA (1) ZA201306515B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5524215B2 (ja) 2008-09-19 2014-06-18 ファイザー・インク 抗菌剤として有用なヒドロキサム酸誘導体
PT2512474E (pt) 2009-12-16 2014-12-23 Pfizer Derivados de ácido hidroxâmico n-ligado úteis como agentes antibacterianos
MA34963B1 (fr) 2011-03-07 2014-03-01 Pfizer Derives de fluoro-pyridinone utiles en tant qu'agents antibacteriens
CN103717582B (zh) 2011-04-08 2015-09-30 辉瑞大药厂 用作抗菌剂的异*唑衍生物
US8809333B2 (en) 2011-04-08 2014-08-19 Pfizer Inc. Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
AR097617A1 (es) 2013-09-13 2016-04-06 Actelion Pharmaceuticals Ltd Derivados antibacterianos del 2h-indazol
WO2015085238A1 (en) * 2013-12-05 2015-06-11 The Regents Of The University Of California, A California Corporation Inhibitors of lpxc
JP6407288B2 (ja) * 2013-12-19 2018-10-17 イドーシア ファーマシューティカルズ リミテッドＩｄｏｒｓｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ 抗菌性１ｈ−インダゾール及び１ｈ−インドール誘導体
AR099612A1 (es) 2014-03-04 2016-08-03 Actelion Pharmaceuticals Ltd Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona
JP6514716B2 (ja) 2014-04-22 2019-05-15 ノバルティス アーゲー ＬｐｘＣ阻害剤としてのイソオキサゾリンヒドロキサム酸誘導体
EP3143007B1 (en) * 2014-05-16 2018-07-11 Idorsia Pharmaceuticals Ltd Antibacterial quinazoline-4(3h)-one derivatives
PT3152199T (pt) 2014-06-03 2018-11-26 Idorsia Pharmaceuticals Ltd Compostos de pirazol e a sua utilização como bloqueadores de canais de cálcio do tipo t
CA2963875A1 (en) 2014-11-19 2016-05-26 Actelion Pharmaceuticals Ltd Antibacterial benzothiazole derivatives
MX2017007980A (es) 2014-12-16 2017-09-29 Novartis Ag Compuestos de isoxazol de acido hidroxamico como inhibidores de lpxc.
CN104876883B (zh) * 2015-06-05 2017-11-28 安徽联创生物医药股份有限公司 抗失眠药物苏沃雷生中间体的合成方法
AR105646A1 (es) 2015-08-11 2017-10-25 Actelion Pharmaceuticals Ltd Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida
AR105889A1 (es) * 2015-09-03 2017-11-22 Actelion Pharmaceuticals Ltd Compuestos antibacterianos 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituidos
EP3468957B1 (en) 2016-06-14 2020-08-26 Novartis Ag Crystalline form of (r)-4-(5-(cyclopropylethynyl)isoxazol-3-yl)-n-hydroxy-2-methyl-2-(methylsulfonyl)butanamide as an antibacterial agent
EP3554490B1 (en) 2016-12-16 2022-02-16 Idorsia Pharmaceuticals Ltd Pharmaceutical combination comprising a t-type calcium channel blocker
JP6972144B2 (ja) 2017-02-06 2021-11-24 イドーシア ファーマシューティカルズ リミテッドIdorsia Pharmaceuticals Ltd １−アリール−１−トリフルオロメチルシクロプロパンを合成するための新規な方法
CN111867600A (zh) * 2018-03-15 2020-10-30 辉瑞大药厂 用作抗菌剂的吡啶酮和嘧啶酮磷酸盐和硼酸盐
US11981696B2 (en) 2018-03-15 2024-05-14 Pfizer Inc. Fluoro-pyridinone phosphates and boronates useful as antibacterial agents
CN110699312B (zh) * 2019-11-28 2022-08-12 西北农林科技大学 一种猪种布鲁氏菌bi-1基因缺失菌株及其构建方法和应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769461A (en) 1986-09-16 1988-09-06 American Home Products Corporation Quinolinyl benzene hydroxamic acids as anti-inflammatory/antiallergic agents
US5110831A (en) 1990-11-30 1992-05-05 Du Pont Merck Pharmaceutical Company Vinylogous hydroxamic acids and derivatives thereof as 5-lipoxygenase inhibitors
CA2320476A1 (en) 1998-02-07 1999-08-12 British Biotech Pharmaceuticals Limited Antibacterial agents
GB9925470D0 (en) 1999-10-27 1999-12-29 Smithkline Beecham Plc Novel compounds
WO2002074298A1 (fr) 2001-03-21 2002-09-26 Ono Pharmaceutical Co., Ltd. Inhibiteurs de production d'il-6
ES2180456B1 (es) 2001-07-20 2004-05-01 Laboratorios S.A.L.V.A.T., S.A. Isoxazoles sustituidos y su utilizacion como antibioticos.
RS52392B (en) * 2002-02-14 2013-02-28 Pharmacia Corporation SUBSTITUTED PYRIDINONES AS P38 MAP KINASE MODULATORS
CA2512582C (en) 2003-01-08 2014-07-08 University Of Washington Antibacterial agents
GB0302431D0 (en) 2003-01-30 2003-03-05 Glaxo Group Ltd Novel compounds
US7495006B2 (en) 2004-12-10 2009-02-24 Emory University 2′ and 3′-substituted cyclobutyl nucleoside analogs for the treatment of viral infections and abnormal cellular proliferation
WO2006118155A1 (ja) 2005-04-27 2006-11-09 Ishihara Sangyo Kaisha, Ltd. ビフェニル誘導体又はその塩、並びにそれらを有効成分として含有する農園芸用殺菌剤
WO2006124897A2 (en) 2005-05-13 2006-11-23 Lexicon Genetics Incorporated Methods and compositions for improving cognition
WO2007069020A2 (en) * 2005-12-15 2007-06-21 Vicuron Pharmaceuticals Inc. N-hydroxyamide derivatives possessing antibacterial activity
US20080085893A1 (en) 2006-10-06 2008-04-10 Shyh-Ming Yang Matrix metalloprotease inhibitors
WO2009008905A1 (en) 2007-02-01 2009-01-15 Panthera Biopharma, Llc. Hydroxamic acid derivatives of phenoxy-acetic acids and analogs useful as therapeutic agents for treating anthrax poisoning
JP5227304B2 (ja) 2007-02-28 2013-07-03 大正製薬株式会社 新規なヒドロキサム酸誘導体
US20080234297A1 (en) 2007-03-20 2008-09-25 Changgeng Qian HSP90 Inhibitors Containing a Zinc Binding Moiety
CN101239978A (zh) * 2008-03-05 2008-08-13 南方医科大学 一种咪唑并吡啶类化合物
WO2010017060A1 (en) * 2008-08-04 2010-02-11 Schering Corporation Urea derivatives as antibacterial agents
JP5455913B2 (ja) 2008-08-27 2014-03-26 大正製薬株式会社 ナフチリジン−ｎ−オキシドを有する新規ヒドロキサム酸誘導体
US8372885B2 (en) 2008-09-17 2013-02-12 Novartis Ag Organic compounds and their uses
JP5524215B2 (ja) 2008-09-19 2014-06-18 ファイザー・インク 抗菌剤として有用なヒドロキサム酸誘導体
WO2010100475A1 (en) 2009-03-02 2010-09-10 Astrazeneca Ab Hydroxamic acid derivatives as gram-negative antibacterial agents
EP2443119A1 (en) * 2009-06-16 2012-04-25 Schering Corporation Gamma secretase modulators
EP2443121A2 (en) * 2009-06-16 2012-04-25 Schering Corporation Gamma secretase modulators
PT2512474E (pt) * 2009-12-16 2014-12-23 Pfizer Derivados de ácido hidroxâmico n-ligado úteis como agentes antibacterianos
MA34963B1 (fr) 2011-03-07 2014-03-01 Pfizer Derives de fluoro-pyridinone utiles en tant qu'agents antibacteriens
US8809333B2 (en) 2011-04-08 2014-08-19 Pfizer Inc. Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
CN103717582B (zh) 2011-04-08 2015-09-30 辉瑞大药厂 用作抗菌剂的异*唑衍生物

Also Published As

Publication number Publication date
KR101593288B1 (ko) 2016-02-11
AU2012226473A1 (en) 2013-09-05
AR085615A1 (es) 2013-10-16
CU20130117A7 (es) 2013-10-29
CN104529883A (zh) 2015-04-22
DOP2013000200A (es) 2014-06-15
US8779148B2 (en) 2014-07-15
GT201300213A (es) 2014-06-06
CA2828337C (en) 2016-05-03
TN2013000353A1 (fr) 2015-01-20
US20120232083A1 (en) 2012-09-13
CR20130403A (es) 2013-09-18
ES2626457T3 (es) 2017-07-25
SG192766A1 (en) 2013-09-30
GEP20156370B (en) 2015-09-25
WO2012120397A1 (en) 2012-09-13
IL228100A0 (en) 2013-09-30
ECSP13012928A (es) 2013-11-29
CO6761338A2 (es) 2013-09-30
EP2683689B1 (en) 2017-04-12
EA201391072A1 (ru) 2014-02-28
KR20130131459A (ko) 2013-12-03
MX2013010276A (es) 2013-10-01
CN103443079B (zh) 2015-06-03
BR112013022536A2 (pt) 2016-11-29
HK1209734A1 (en) 2016-04-08
TWI453197B (zh) 2014-09-21
UA107423C2 (en) 2014-12-25
AP2013007074A0 (en) 2013-08-31
CL2013002417A1 (es) 2013-12-13
US20140057919A1 (en) 2014-02-27
EP2683689A1 (en) 2014-01-15
UY33936A (es) 2012-10-31
AU2012226473B8 (en) 2015-10-15
JP2014507464A (ja) 2014-03-27
AU2012226473B2 (en) 2015-06-11
TW201249798A (en) 2012-12-16
CN103443079A (zh) 2013-12-11
AP3336A (en) 2015-07-31
EA024782B1 (ru) 2016-10-31
MA34963B1 (fr) 2014-03-01
HK1191951A1 (en) 2014-08-08
BR112013022536B1 (pt) 2020-05-26
JP5620020B2 (ja) 2014-11-05
CA2828337A1 (en) 2012-09-13
NI201300077A (es) 2014-01-07
ZA201306515B (en) 2014-05-28
NZ614205A (en) 2014-06-27
MX341977B (es) 2016-09-07
US8624034B2 (en) 2014-01-07

Similar Documents

Publication Publication Date Title
PE20140397A1 (es) Derivados de fluoro-piridinona utiles como agentes antibacterianos
PE20090288A1 (es) Derivados de quinoxalina como inhibidores de la pi3 quinasa
PE20141120A1 (es) Compuestos heterociclicos
PE20090714A1 (es) Imidazopiridazinas y pirrolo-pirimidinas sustituidas como inhibidores de cinasa de lipido
PE20141828A1 (es) 6-alquinilo piridinas como mimeticos smac
PE20081800A1 (es) NUEVOS DERIVADOS DE 3-([1,2,4]TRIAZOLO[4,3-a]PIRIDIN-7-IL)BENZAMIDA
PE20140623A1 (es) Halogenoalquil-1,3-oxazinas como inhibidores de la bace1 y/o bace2
PE20140865A1 (es) Inhibidores de la tirosina-quinasa de bruton
PE20141404A1 (es) Derivados de tieno[3,2-d]pirimidina que tienen actividad inhibidora por las quinasas de las proteinas
PE20081845A1 (es) Nuevos derivados de aminopirimidina como inhibidores de plk1
PE20170666A1 (es) 2-(morfolin-4-il)-1,7-naftiridinas
PE20170444A1 (es) Herbicidas de piperidinona
PE20110196A1 (es) 5-alquinil-pirimidinas
PE20171177A1 (es) Compuestos aminopirimidinilo inhibidores de jak
PE20090237A1 (es) Derivados de sulfonamidas como inhibidores de los canales de sodio
PE20161073A1 (es) Amino-heteroaril-benzamidas como inhibidores de cinasa
PE20141308A1 (es) Nuevos compuestos inhibidores de la fosfodiesterasa tipo 10a
PE20090773A1 (es) Derivados de morfolina pirimidina
PE20091000A1 (es) Inhibidores de la replicacion del virus de la inmunodeficiencia humana
PE20141283A1 (es) Nuevos derivados biciclicos de dihidroisoquinolin-1-ona
PE20091527A1 (es) Derivados de piridazinona
PE20120049A1 (es) Derivados de 3-anilino-tieno[3, 2-c]piridina como inhibidores de quinasa mek
PE20130306A1 (es) Morfolinopirimidinas y su uso en terapia
PE20090774A1 (es) Compuestos heterociclicos como moduladores de la enzima dgat1
PE20142376A1 (es) Fluormetil-5,6-dihidro-4h-[1,3]oxazinas

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed